Human papillomavirus prevalence in invasive cervical carcinoma by HIV Status

dc.contributor.author	De Vuyst, Hugo
dc.contributor.author	Ndirangu, Gathari
dc.contributor.author	Moodley, Manivasan
dc.contributor.author	Tenet, Vanessa
dc.contributor.author	Estambale, Benson B
dc.contributor.author	Meijer, Chris JLM
dc.contributor.author	Snijders, Peter JF
dc.contributor.author	Clifford, Gary
dc.contributor.author	Franceschi, Silvia
dc.date.accessioned	2013-03-19T15:45:37Z
dc.date.available	2013-03-19T15:45:37Z
dc.date.issued	2012-04-19
dc.identifier.citation	http://www.infectagentscancer.com/content/7/S1/O12
dc.identifier.uri	http://dx.doi.org/10.1186/1750-9378-7-S1-O12
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/14688
dc.description.abstract	Data on the prevalence of human papillomavirus (HPV) types in invasive cervical carcinoma (ICC) in women with HIV are scarce but are essential to elucidate the influence of immunity on the carcinogenicity of different HPV types, and the potential impact of prophylactic HPV vaccines in populations with high HIV prevalence
dc.title	Human papillomavirus prevalence in invasive cervical carcinoma by HIV Status
dc.type	Journal Article
dc.date.updated	2013-03-19T15:45:37Z
dc.description.version	Peer Reviewed
dc.language.rfc3066	en
dc.rights.holder	Hugo De Vuyst et al.; licensee BioMed Central Ltd.